In addition to reduced P-gp expression, the efflux function of P-gp appears diminished in individuals with AD, with positron emission tomography imaging demonstrating an increased brain accumulation of the P-gp substrate [11C]verapamil compared to those without AD [17]. Here, PGP is linked to Alzheimer disease.